Company Filing History:
Years Active: 2017-2020
Title: Rolf Inge Skotheim: Innovator in Colorectal Cancer Detection
Introduction
Rolf Inge Skotheim is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of medical diagnostics, particularly in the detection of colorectal cancer. With a total of 4 patents to his name, Skotheim's work is pivotal in advancing cancer detection methodologies.
Latest Patents
Skotheim's latest patents focus on innovative methods and biomarkers for the analysis of colorectal cancer. One of his inventions relates to the use of protein biomarkers for the detection of colorectal cancer in various biological samples, including tissue, biopsy, stool, blood, plasma, and serum samples. These methods not only aid in the detection of colon cancer but also provide prognostic information for colorectal cancer patients. Another patent emphasizes gene expression biomarkers for similar applications, further enhancing the capabilities of cancer diagnostics.
Career Highlights
Rolf Inge Skotheim is affiliated with Oslo Universitetssykehus HF, where he continues to contribute to research and development in the medical field. His work has been instrumental in improving diagnostic techniques that can lead to better patient outcomes.
Collaborations
Skotheim collaborates with esteemed colleagues such as Ragnhild A Lothe and Guro Elisabeth Lind. Their combined expertise fosters a collaborative environment that enhances the research and development of innovative cancer detection methods.
Conclusion
Rolf Inge Skotheim's contributions to colorectal cancer detection through his patents and collaborations highlight his commitment to improving medical diagnostics. His work is essential in the ongoing fight against cancer, providing hope for better detection and treatment options for patients.